← SynDRA
dihydroxyphenylglycine
SynDRA canonical compound SYN0056465 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GRM5 |
|---|
| Mechanism of action | Glutamate receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Glutamate receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PIK3C2G
- PI4KB
- PHKG1
- PHKA2
- PGR
- PDPK1
- PDGFRB
- PDGFRA
- PDE5A
- PDE2A
- PAK6
- PAK5
- PAK4
- PAK3
- PAK2
- PAK1
- OXSR1
- OPRL1
- NUAK2
- NUAK1
- NTRK3
- NTRK2
- NTRK1
- NR3C1
- PIK3C2B
- PIK3C3
- NIM1K
- PIK3CA
- PRKACB
- PRKACA
- PRKAA2
- PRKAA1
- PNCK
- PLK4
- PLK3
- PLK2
- PLK1
- PKN2
- PKN1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- 3,5-Dihydroxyphenylglycine
- 2-amino-2-(3,5-dihydroxyphenyl)acetic acid
- 3,5-Dhpg
- 5YR2N37E6D
- DHPG-3,5
- RefChem:91549
- DTXCID201437260
- (RS)-3,5-DHPG
- DL-3,5-dihydroxyphenylglycine
- (R,S)-3,5-DHPG
- amino(3,5-dihydroxyphenyl)acetic acid
- (RS)-3,5-Dihydroxyphenylglycine
- alpha-Amino-3,5-dihydroxybenzeneacetic acid
- UNII-5YR2N37E6D
- 2-amino-2-(3,5-dihydroxyphenyl)-acetic acid
- Benzeneacetic acid, alpha-amino-3,5-dihydroxy-
- S-3,5-dihydroxyphenylglycine
- GTPL1367
- SCHEMBL1512962
- CHEBI:93822
- HOOWCUZPEFNHDT-UHFFFAOYSA-N
- HMS3266G15
- HMS3411E15
- HMS3675E15
- WFA25566
- EBC-06322
- EX-A12377
- HB0026
- HY-12598A
- AKOS006230321
- NCGC00015338-03
- NCGC00024545-02
- DA-48824
- DL-2-(3,5-DIHYDROXYPHENYL)GLYCINE
- CS-0020572
- NS00014709
- E98650
- EN300-298606
- T11032
Look up dihydroxyphenylglycine in the interactive SynDRA portal →